Lifeward Ltd. is a medical device manufacturer that develops exoskeleton and robotic rehabilitation technologies for individuals with physical and neurological conditions. The company's product portfolio includes the ReWalk personal exoskeleton for mobility assistance, the ReStore soft exo-suit for post-stroke rehabilitation, the AlterG Anti-Gravity System for physical therapy and athletic training, MyoCycle devices, and the ReBoot personal soft exo-suit designed for home and community use. These devices serve rehabilitation facilities, athletic training centers, and individual users across multiple geographies.
The company operates primarily in the orthopedic and prosthetic appliances sector, with an 80-person workforce based in Yokneam Illit, Israel. Lifeward markets and sells its products through both direct channels to institutions and individuals as well as third-party distributors, with established operations in the United States, Europe, and Asia-Pacific regions. The company was incorporated in 2001 and underwent a rebranding from ReWalk Robotics Ltd. to Lifeward Ltd. in September 2024, reflecting a broader portfolio expansion beyond its original exoskeleton focus.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-3.33 | $-3.33 | -800.0% | |
| 2023 | $-0.37 | $-0.37 | -19.4% | |
| 2022 | $-0.31 | $-0.31 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-07 | 0001178913-25-000736 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0001178913-24-000730 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0001178913-23-000722 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0001178913-22-000800 | SEC ↗ |
| 2020-12-31 | 2021-02-18 | 0001178913-21-000678 | SEC ↗ |
| 2019-12-31 | 2020-02-20 | 0001213900-20-004363 | SEC ↗ |
| 2018-12-31 | 2019-02-08 | 0001213900-19-001871 | SEC ↗ |
| 2017-12-31 | 2018-03-08 | 0001607962-18-000007 | SEC ↗ |
| 2016-12-31 | 2017-02-17 | 0001607962-17-000006 | SEC ↗ |
| 2015-12-31 | 2016-02-29 | 0001607962-16-000007 | SEC ↗ |